U.S. pharmaceutical giant Pfizer Inc. will request Friday that Japan approve its COVID-19 vaccine for the novel coronavirus, according to sources familiar with the move. The United States and Britain have already begun administering the coronavirus vaccine jointly developed by Pfizer and its German partner BioNTech SE.